Patients' drug costs surge for some neurologic conditions

2 May 2019 - Many patients with neurologic disorders like multiple sclerosis, epilepsy and Parkinson’s disease have seen steep increases ...

Read more →

Expanding the scope of costs and benefits for economic evaluations in health: some words of caution

18 April 2019 - Discussions regarding the appropriate scope of costs and benefits for inclusion in economic evaluation in healthcare have ...

Read more →

Next phase in effective cost control in health care

7 March 2019 - There is some good news on cost control in the United States.  ...

Read more →

Future unrelated medical costs need to be considered in cost effectiveness analysis

5 March 2019 - New medical technologies that prolong life result in additional health care use in life years gained. Some ...

Read more →

Address health care costs not just insurance, says Medibank

28 February 2019 - Medibank Private has told federal Labor it should focus on industry-wide health care cost "drivers" and ...

Read more →

Trump proposals could increase health costs for consumers

21 January 2019 - President Trump has repeatedly vowed to reduce drug prices and to lower out-of-pocket drug costs, but the ...

Read more →

Will price be a barrier to new cancer immunotherapy?

19 January 2019 - Advisory group CADTH recommends no funding for new CAR-T therapy until drug company lowers cost. ...

Read more →

Why pharmaceutical companies are on a shopping binge

14 January 2019 - With the cost of R&D so high, it may make sense to spend money on a competitor. ...

Read more →

Cost recovery and Pharmaceutical Benefits Scheme process improvements information forums

14 January 2019 - The Department of Health will be hosting information forums in both Sydney and Melbourne regarding amendments ...

Read more →

German health minister calls for faster adoption of biosimilar drugs

14 November 2018 - Germany’s health minister Jens Spahn has called for faster adoption of cheaper copies of biotech drugs ...

Read more →

Biosimilar drugs promise to slash health care costs in rich countries

8 November 2018 - The world's top-selling drug now faces biosimilars that are 80% cheaper. ...

Read more →

Update of the Cost Resource Manual

5 November 2018 - PHARMAC recently updated the Cost Resource Manual – the online list of standard costs and prices ...

Read more →

Pharma makes lobbying push to roll back seniors' drug discounts

6 November 2018 - Drug industry stands to lose $1.9 billion under February law. ...

Read more →

Novartis says SMA gene therapy is cost-effective at $4-5 million per patient

5 November 2018 - Novartis, which is shifting into rare diseases, said on Monday it believes its new gene therapy ...

Read more →

Almost half of new US cancer patients lose their entire life savings

23 October 2018 - According to a new study published in the American Journal of Medicine, 42% of new cancer patients ...

Read more →